Author:
Kesteman Thomas,Yombi Jean-Cyr,Gigi Jacques,Durez Patrick
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference15 articles.
1. Slifman NR, Gershon SK, Lee JH et al (2003) Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum 48:319–324
2. Keane J, Gershon S, Wise RP et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098–1104
3. Gomez-Reino JJ, Carmona L, Valverde VR et al (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48:2122–2127
4. Durez P, Vander Cruyssen B, Westhovens R et al (2006) Four-years effects of infliximab utilisation in a large multicentric Belgian cohort of patients presenting refractory rheumatoid arthritis. Ann Rheum Dis 65(Suppl II):349
5. Schett G, Herak P, Graninger W et al (2005) Listeria-associated arthritis in a patient undergoing etanercept therapy: case report and review of the literature. J Clin Microbiol 43:2537–2541
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献